biologic therapy
90% Cost Relief in Chronic Disease Management by 2026
Early initiation of biologics in Crohn's disease can shave up to $800,000 off Medicare Part B expenditures per 100 patients, delivering up to 90% cost relief by 2026. This saving stems from avoided surgeries and hospital stays, and it reshapes chronic disease management across the NHS and